Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)

Market Cap	12.46B -15.1%
Revenue (ttm)	4.52B -6.0%
Net Income	667.20M -29.5%
EPS	1.00 -30.0%
Shares Out	663.61M
PE Ratio	18.76
Forward PE	15.85
Dividend	0.46 (2.45%)
Ex-Dividend Date	May 20, 2026

Volume	12,369,897
Open	18.65
Previous Close	18.78
Day's Range	17.96 - 18.72
52-Week Range	17.30 - 23.99
Beta	0.29
Analysts	Hold
Price Target	23.05 (+27.28%)
Earnings Date	Aug 25, 2026

About SHA:600529

Shandong Pharmaceutical Glass Co.Ltd engages in research and development, production, and sale of various pharmaceutical glass packaging products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection vial comprising type I/II/III. It also provides tubular glass products, such as glass tubes for pharma use, other tubular bottle with screw neck finish,...

• Industry: Packaging & Containers
• Sector: Consumer Discretionary
• Founded: 1970
• Employees: 6,775
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600529

Financial Performance

In 2025, SHA:600529's revenue was 4.47 billion, a decrease of -8.78% compared to the previous year's 4.90 billion. Earnings were 689.63 million, a decrease of -26.87%.